Медицинские науки

Оценка распространенности основных факторов риска сердечно-сосудистых заболеваний / Evaluation of prevalence of main risk factors of cardiovascular diseases

Джорупбекова Канзаада Шербековна / Dzhorupbekova Kanzaada - научный сотрудник, отделение профилактической медицины, клинический руководитель;

Кыдыралиева Рыскуль Бекбаевна / Kydyralieva Ryskul - доктор медицинских наук;

Алтымышева Алийна Тариеловна / Altymysheva Aliina - кандидат медицинских наук, заведующая отделением, консультативно-диагностическое отделение, старший научный сотрудник,

отделение профилактической медицины, Национальный центр кардиологии и терапии, г. Бишкек, Кыргызская Республика

Аннотация: распространенность сердечно-сосудистых заболеваний сегодня приобретает характер пандемии во всем мире, их последствия могут приводить к потере трудоспособности, инвалидизации и смерти пациентов. В настоящем обзоре литературы приведены данные о распространенности факторов риска сердечно-сосудистых заболеваний в мире, таких как артериальная гипертензия, курение, гиперхолестеринемия, избыточная масса тела и ожирение, низкая физическая активность, сахарный диабет, как крупных научных исследований, так и данных ВОЗ. Данные статистические показатели должны лечь в основу разработки профилактических программ и стратегий контроля сердечно-сосудистых заболеваний.

Abstract: the prevalence of cardiovascular disease becomes pandemic in the world today; it may lead to loss of labor incapacity, permanent disability and death of patients. Current review of literature provides data from major scientific research studies and WHO data on the prevalence of risk factors of cardiovascular disease in the world, such as hypertension, smoking, high cholesterol, overweight and obesity, physical inactivity, diabetes. These statistical data should form the basis for the development of prevention programs and strategies for the control of cardiovascular disease.

Ключевые слова: сердечно-сосудистые заболевания, факторы риска, гиперхолестеринемия, сахарный диабет, ожирение, курение.

Keywords: cardiovascular diseases, risk factors, hypercholesterolemia, diabetes, obesity, smoking.

Литература

1. Sytkowski P. A., Kannel W. B., D'Agostino R. B.Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. // .,1990. Vol. 322. № 23. P. 1635-1641.
2. Posner B. M., Franz M. M., Quatromoni P. A. et al.Secular trends in diet and risk factors for cardiovascular disease: the Framingham Study. // .,№ 171-179.
3. Schauffler H. H., D'Agostino R. B., Kannel W. B.Risk for cardiovascular disease in the elderly and associated Medicare costs: the Framingham Study. // .,№146-154.
4. Куликов В. А. Фремингемское исследование сердца: 65 лет изучения причин атеросклероза. // Вестник ВГМУ, 2012. 11. № 2. С. 16-24.
5. Kannel W. B. Risk factor analysis. // Progr. Cardiovasc. Dis., 1984. Vol. 26. № 4. P. 309-332.
6. Метелица В. И., Мазур Н. А. Эпидемиология и профилактика ишемической болезнью сердца.М.: Медицина, 1976. 166 с.
7. Kagan A. et al.
8. Kannel W. B., Mcgee D. L. Diabetes and cardiovascular risk factors: the Framingham study. // Circulation, 1979. 59.
9. Yusuf S., Hawken, S., Ounpuu, S. et al.INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. // Lancet,2004. 364. Р. 937–952.
10. Cooney M. T., Storey S., Taylor L. et al. EUROASPIRE III-a comparison of Irish and European results. // Ir. Med. J., 2009. Vol. 102.№ 4.
11. Danaei G., Ding E. L., Mozaffarian D. et al.The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. // .,№
12. Giampaoli S., Palmieri L., Donfrancesco C. et al.Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey Research Group. // Eur J Prev Cardiol., 2015. Sep; 22 (2 Suppl). Р. 9-37.
13. Boersma E., Keil U., De Bacquer D. et al.EUROASPIRE I and II Study Groups. Blood pressure is insufficiently controlled in European patients with established coronary heart disease. // J. Hypertens., 2003. Vol. 21. P. 1831-1840.
14. Scholte op Reinmer W., Gitt S., Boersma E. et al.Carsdiovascular diseases in Europe. Euro Heart Survey. European Society of cardiology. France, 2006.
15. Donald Lloyd-Jones, Robert Adams, Mercedes Carnethon et al. Heart Disease and Stroke Statistics 2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. // Circulation, 2009. Vol. 119. P. e21-e181.
16. Williams B.The changing face of hypertension treatment: treatment strategies from the 2007 ESH/ESC hypertension Guidelines. //,
17. Guimarães Filho G. C., Sousa A. L., Jardim Tde S.et al. Progression of blood pressure and cardiovascular outcomes in hypertensive patients in a reference center. // Arq Bras Cardiol.,. Р. 292-8.
18. da Silva T. L., Klein C. H., Nogueira Ada R. et al. Cardiovascular mortality among a cohort of hypertensive and normotensives in Rio de Janeiro – Brazil, 1991-2009. //BMC Public Health., –15:623.
19. Global Health Observatory Data Repository//
20. Addo J., Smeeth L., Leon D. A. Hypertension in sub-saharan Africa: a systematic review. // Hypertension,2007. . 1012-8.
21. Yoon Y. E., Rivera J. J., Kwon D. A. et al. National Cholesterol Education Panel III guidelines performance role in preventing myocardial infarction in a large cohort without a history of coronary artery disease: Korea Acute Myocardial Infarction Registry study. // .,№109-113.
22. Ratovoson R., Rasetarinera O. R.  Andrianantenaina I. et al. Hypertension, a Neglected Disease in Rural and Urban Areas in Moramanga, Madagascar. // PLoS One, 2015. Sep. 10. 10 (9).
23. Torlasco C., Calvanese C., Faini A. et al. Prevalence of hypertension and other cardiovascular risk factors in participants in the 2014 Hypertension World Day campaign in Italy. // J Hypertens.,2015. Jun.; 33 Suppl. 1:e68.
24. Battistoni A., Canichella F., Pignatelli G. et al. Hypertension in Young People: Epidemiology, Diagnostic Assessment and Therapeutic Approach. // High Blood Press Cardiovasc Prev.,.
25. The European health report, 2015. Targets and beyond Reaching new frontiers in evidence. [Electronic resource]. URL: http://www.euro.who.int/en/data-and-evidence/european-health-report/ (date of access: 08.12-2016).
26. W. Annual report, 2014. [Electronic resource]. URL //www.world-heart-federation.org/ (date of access: 08.12-2016).
27. Scholte op Reimer WJM., de Swart E., De Bacquer D. et al. Smoking behaviour in European patients with established coronary heart disease. // Eur. Heart J.,35-41.
28. Adhikari B., Kahende J., Malarcher A. et al.Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses- United States, 2000-2004. // Morbidity and Mortality Weekly Report, 2008. Vol. 57. № 1226-1228.
29. Zhao J.,  Pachanee C. A, Yiengprugsawan V. et al. Smoking, smoking cessation, and 7-year mortality in a cohort of Thai adults. // Popul Health Metr.,2015. Oct. 27. 13:30.
30. Ritter C., Gayet-Ageron A., Buth S., Stöver H. Tobacco use among prison staff in Germany: a cross-sectional study. // Eur J Public Health.,.
31. Syamlal G., Mazurek J. M.,  Storey E. Cigarette  Smoking  Prevalence Among Adults Working in the Health Care and Social Assistance Sector, 2008 to 2012. // J Occup Environ Med., 2015. . 1107-12.
32. Gordon D. J., Probstfield J. L., Garrison R. J. et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. // Circulation,№
33. Danesh J., Collins R., Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. // Circulation,№
34. Sarwar N., Danesh J., Eiriksdottir G. et al.Triglycerides and the Risk of Coronary Heart Disease. 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies. // Circulation, 2006. Vol. 115. №
35. Aref-Eshghi E., Leung J., Godwin M. et al.Low density lipoprotein cholesterol control status among Canadians at risk for cardiovasculardisease: findings from the Canadian Primary Care Sentinel Surveillance Network Database. // Lipids Health Dis.,. 24. 14:60.
36. Kremers S., Reubsaet A., Martens M. et al.Systematic prevention of overweight and obesity in adults: a qualitative and quantitative literature analysis. //Obesity Reviews, 2009.
37. Amin F., Fatima S. S., Islam N., Gilani A. H. Prevalence of obesity and overweight, its clinical markers and associated factors in a high riskSouth-Asian population. // BMC Obes., 2015. Mar. 18. 2:16.
38. Bancej C., Jayabalasingham B., Wall R. W. et al. Trends and projections of obesity among Canadians. // Health Promot Chronic Dis Prev Can., 2015. Sep. 35. 109-12.
39. Peeters A., Barendregt J. J., Willekens F. et al.NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. // Ann. Intern. Med.,
40. Donald Lloyd-Jones, Robert Adams, Mercedes Carnethon et al. Heart Disease and Stroke Statistics 2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. // Circulation, 2009. Vol. 119. P. e21-e181.
41. Warren Andersen S., Shu X. O., Gao Y. T. et al.Prospective Cohort Study of Central Adiposity and Risk of Death in Middle Aged and Elderly Chinese. // PLoS One, 2015. Sep. 16. 10.
42. Choi B., Steiss D., Garcia-Rivas J. et al. Comparison of body mass index with waist circumference and skinfold-based percent body fat in firefighters: adiposity classification and associations with cardiovascular disease risk factors. // Int Arch Occup Environ Health., 2015. Aug.
43. Chearskul S., Sriwijitkamol A., Kooptiwut S. et al. Cardiometabolic risk in Thai adults with type 2 diabetes mellitus: obese versus non-obese. // J Med Assoc Thai, 2015.. 528-34.
44. Kwagyan J., Retta T. M., Ketete M. et al. Obesity and Cardiovascular Diseases in a High-Risk Population: Evidence-Based Approach to CHD Risk Reduction. // Ethn Dis., 2015. Spring. 25. 208-13.
45. Derezinski T., Wolf J., Szyndler A. et al.Comparison of incident hypertension overweight and obesity in a representative polish junior high-school population in 2005 VS. 2014. // J Hypertens., 2015. Jun.;33 Suppl. 1.
46. Carolan E., Hogan A., O'Connell J. et al.The prevalence of cardiovascular risk factors in obese children. // , 2015. May. 108. 134-6.
47. Gökler M. E., Buğrul N., Metintaş S., Kalyoncu C. Adolescent obesity and associated cardiovascular risk factors of rural and urban life (Eskisehir, Turkey). // Cent Eur J Public Health., 2015.. 20-5.
48. Hardman A., Stensel D. Physical activity and health: the evidence explained. London, Routledge, 2003.
49. Cavill N., Bauman A. Changing the way people think about health-enhancing physical activity: do mass media campaigns have a role? // Journal of Sports Science, 2004. Vol. 22. P. 171–190.
50. Aadahl M., von Huth Smith L., Pisinger C. et al.Five-year change in physical activity is associated with changes in cardiovascular disease risk factors. The Inter99 study. // Prev. Med.,.
51. Juraschek S. P., Blaha M. J., Whelton S. P. et al. Physical fitness and hypertension in a population at risk for cardiovascular disease: the Henry Ford ExercIse Testing (FIT) Project. // J Am Heart Assoc., 2014. Dec.;3.
52. Soares Ferreira F., Ramos Duarte J. A. Overweight, obesity, physical activity, cardiorespiratory and muscular fitness in a Portuguese sample of high school adolescents. // Minerva Pediatr., 2013. Feb; 65 (1). 83-91.
53. Lavie C. J., Arena R., Swift D. L. et al.Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. // Circ Res., 2015. Jul. 3;117. 207-19.
54. Myers J., McAuley P., Lavie C. J. et al.Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status. // Prog Cardiovasc Dis., 2015. Jan.-Feb. 57. 306-14.
55. Echouffo-Tcheugui J. B., Butler J., Yancy C. W., Fonarow G. C. Association of Physical Activity or Fitness With Incident Heart Failure: A Systematic Review and Meta-Analysis. // Circ Heart Fail., 2015. Sep. 8. 853-61.
56. Ivy J., Zderic T., Fogt D. Prevention and treatment of non-insulin-dependent diabetes mellitus. In: Holloszy J. ed. Exercise and sport sciences reviews. Philadelphia, Lippincott Williams and Wilkins, 1999.
57. Tuomilehto J. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. // New England Journal of Medicine, 2001. Vol. 344. № 1343-1350.
58. Li J., Dong Y., Wu T. et al.Differences between western and Asian type 2 diabetes patients in the incidence of vascular complications andmortality: A systematic review of randomized controlled trials on lowering blood glucose. // J Diabetes, 2015. Dec.
59. Ray K. K., Seshasai S. R., Wijesuriya S. et al.Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomized controlled trials. // Lancet,№ 1765-1772.
60. Church T. S., Thompson A. M., Katzmarzyk P. T. et al.Metabolic syndrome and diabetes, alone and in combination, as predictors of cardiovascular disease mortality among men. // Diabetes Care,№
61. Preis S. R., Hwang S. J., Coady S. et al., 2009 / Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005 // Circulation, 2009. 119. 1728-1735
62. Matteucci E., Giampietro O. Epidemiology of cardiovascular disease in patients with type 1 diabetes: European perspective. // Exp Clin Endocrinol Diabetes, 2014. Apr. 122. 208-14.
63. Ramírez-Prado D., Palazón-Bru A., Folgado-de-la Rosa D. M. et al. Predictive models for all-cause and  cardiovascular  mortality in type 2 diabetic inpatients. A cohort study. // Int J Clin Pract., 2015. Apr. 69. 474-84.

Поделитесь данной статьей, повысьте свой научный статус в социальных сетях